Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
1.610
-0.030 (-1.83%)
At close: Feb 21, 2025, 4:00 PM
1.659
+0.049 (3.04%)
After-hours: Feb 21, 2025, 4:39 PM EST
Taysha Gene Therapies Market Cap
Taysha Gene Therapies has a market cap or net worth of $329.96 million as of February 21, 2025. Its market cap has increased by 13.13% in one year.
Market Cap
329.96M
Enterprise Value
235.29M
1-Year Change
13.13%
Ranking
Category
Stock Price
$1.61
Market Cap Chart
Since the IPO on September 24, 2020, Taysha Gene Therapies's market cap has decreased from $690.43M to $329.96M, a decrease of -52.21%. That is a compound annual growth rate of -15.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 336.11M | -5.20% |
| Dec 31, 2024 | 354.55M | 7.14% |
| Dec 29, 2023 | 330.92M | 134.50% |
| Dec 30, 2022 | 141.12M | -68.52% |
| Dec 31, 2021 | 448.22M | -55.28% |
| Dec 31, 2020 | 1.00B | 45.15% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 780.72B |
| UnitedHealth Group | 470.30B |
| Johnson & Johnson | 380.14B |
| Novo Nordisk | 370.06B |
| AbbVie | 348.39B |
| Abbott Laboratories | 229.17B |
| AstraZeneca | 228.16B |
| Intuitive Surgical | 217.02B |